Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: The use of a disaster epidemiological model for the evaluation of drug teratogenicity

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 9, 2009, Pages 815-825

  Timmermann, Gábor ^a   Ács, Nándor ^b   Bánhidy, Ferenc ^b   Czeizel, Andrew E ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Congenital abnormality; Phenobarbital; Suicide attempt during pregnancy

Indexed keywords

PHENOBARBITAL; UNCLASSIFIED DRUG; VALERIANA COMPOSITA;

ADULT; ARTICLE; BIRTH DEFECT; CHILD; CONGENITAL DISORDER; CONTROLLED STUDY; CRYPTORCHISM; DELIVERY; DIAPHRAGM DISEASE; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG OVERDOSE; FEASIBILITY STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF POISONING; SUICIDE; SUICIDE ATTEMPT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDEMIOLOGIC METHODS; FEMALE; FETAL DEVELOPMENT; HUMANS; HUNGARY; HYPNOTICS AND SEDATIVES; INFANT; MODELS, BIOLOGICAL; PHENOBARBITAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SUICIDE, ATTEMPTED; TERATOGENS; YOUNG ADULT;

EID: 70450199611     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1785     Document Type: Article

References (38)

1. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation (7th edn). Lippincott Williams and Wilkins: Philadelphia, 2005.
2. Shepard TH, Lemire RJ. Catalog of Teratogenic Agents (11th edn). Johns Hopkins Univ. Press: Baltimore, 2004.
3. Czeizel AE. Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis, Ramel C, Lambert B, Magnusson J (eds). Alan R. Liss: New York, 1986; 237-244.
4. Czeizel AE, Gidai J, Petik D, Timmermann G, Puho HE. Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Indian J Pediatr 2008; 24: 11-28.
5. MacMahon B, Pugh TF, Ipsen I. Epidemiologic Methods. Little, Brown and Co.: Toronto, 1960.
6. GeisslerW, Luminal, ein neues subkutan anwendbares, starkwirkendes Hypnotikum. Münch Med Wschr 1912; 17: 922-924.
7. FDA: Food and Drug Administration. Fetal risk summary. Fed Regist 1980; 44: 37434-37467.
8. Yao M, Brown-Woodman PD, Ritchie H. Do the herbal remedies feverfew and valerian have an adverse effect on pregnancy outcome in rat? Birth Defects Res A 2003; 67: 145-146.
9. Czeizel AE, Budapest registry of self-poisoned patients. Mutat Res 1994; 312: 157-163.
10. Czeizel AE, Szentesi I, Szekeres I, Glauber A, Bucski P, Molnár G. Pregnancy outcome and health conditions of offspring of self-poisoned pregnant women. Acta Paediatr Hung 1984; 25: 209-236. (Pubitemid 15224301)
11. Czeizel AE, Szentesi I, Szekeres I, Molnár G, Glauber A, Bucski P. A study of adverse effects on the progeny after intoxication during pregnancy. Arch Toxicol 1988; 62: 1-7. (Pubitemid 18202534)
12. Czeizel AE, Lendvay A. Attempted suicide and pregnancy. Am J Obstet Gynecol 1989; 161: 497.
13. Lendvay A, Czeizel AE. A behavioural teratologic study on offspring of self-poisoned pregnant women. Acta Paediatr Hung 1992; 32: 347-369. (Pubitemid 23159614)
14. Czeizel AE, Tomcsik J, Tímár L. Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 1997; 90: 195-201. (Pubitemid 27318831)
15. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E. Description and, mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996. Teratology 2001; 63: 176-185.
16. Czeizel AE, Intocombining double acute accentdy Cs, Modell B. What proportion of congenital abnormalities can be prevented? Br Med J 1993; 306: 499-503.
17. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Akadémiai Kiadó : Budapest, 1988.
18. Vitéz M, Korányi G, Gönczy E, Rudas T, Czeizel AE. A semiquantitative score system for epidemiological studies of fetal alcohol syndrome. Am J Epidemiol 1984; 119: 301-308. (Pubitemid 14154474)
19. Marden PM, Smith DW, McDonald MJ. Congenital anomalies in the newborn infant including minor variants. J Pediatr 1964; 64: 351-371.
20. Czeizel AE, Bod M, Halász P. Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 1992; 8: 122-127.
21. Rosa F, cit Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation (7th edn). Lippincott Williams and Wilkins: Philadelphia, 2005.
22. Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposures (MADRE). Epilepsia 2000; 41: 1436-1443. (Pubitemid 30813216)
23. Czeizel AE, Petik D, Puhó E. Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent Eur J Public Health 2004; 12: 179-183. (Pubitemid 40070014)
24. De Carolis MP, Romagnoli C, Frezza S, DlUrzo E, Muzil U, Mezza A, et al. Placental transfer of phenobarbital: what is new? Dev Pharmacol Ther 1992; 19: 19-26.
25. Janz D, Fuchs V. Are anti-epileptic drugs harmful when given during pregnancy? German Med Monogr 1964; 9: 20-23.
26. Greenberg G, Inman WHW, Weatherall, JAC, Nelson MM, Forfar JO. Maternal drug histories and congenital abnormalities. Br Med J 1977; 2: 853-856. (Pubitemid 8187368)
27. Robert E, Lofkvist E, Mauguiere F, Robert JM. Evaluation drug therapy and teratogenic risk in a Rhone-Alpes district population of pregnant epileptic women. Eur Neurol 1986; 25: 436-443. (Pubitemid 17179398)
28. Dansky LV, Finnel RH. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades. 2: Human studies. Reprod Toxicol 1991; 5: 301-335.
29. Hill RM, VerniaudWM, HorningMG,McCulley LB,Morgan NF. Infant exposed to antiepileptic drugs. Am J Dis Child 1974; 127: 305-312.
30. Jones KL, Johnson KA, Chamber CC. Pregnancy outcome in women treated with phenobarbital monotherapy. Teratology 1992; 45: 452-453.
31. Thakker JC, Kothari SS, Deshmukh CT, Spiedel BD. Hypoplasia of nails and phalanges: a teratogenic manifestation of phenobarbitone. Indian Pediatr 1991; 28: 73-75.
32. Fedrick J. Epilepsy and pregnancy: a report from the Oxford record linkage study. Br J Med 1973; 2: 442-448.
33. Bethenod M, Frederich A. Les enfants des antiepileptiques. Pediatrie 1975; 30: 227-248.
34. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. John Wright-PSG: Littleton, Mass, 1977.
35. Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsy 1999; 40: 1231-1236. (Pubitemid 29416391)
36. Holmes LB, Harvey EA, Couli BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Eng J Med 2001; 344: 1132-1138.
37. Milkovich L, Van den Berg BJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Eng J Med 1974; 291: 1268-1271.
38. Shapiro S, Hartz SC, Siskind V, Mitchell AA, Slone D, Rosenberg L, et al. Anticonvulsants and prenatal epilepsy in the development of birth defects. Lancet 1976; 1: 272-275.